Simulations Plus Inc. (SLP) announced that it has signed a collaboration agreement with a top-5 pharmaceutical company to add a transdermal and subcutaneous dosing model within its industry gold standard GastroPlus simulation software program.
For comments and feedback: editorial@rttnews.com